April 28 - 29, 2018
Renaissance Phoenix Glendale

Virtual Attendance

Virtual Sessions

The sessions below will be available as live webinars. $90/day for the sessions only, $120/day with CEU credit.

​Friday May 26

​8:15 am - 9:30 am            Opening Plennary

At 1:57 a.m. on Sunday, June 12, 2016, the deadliest mass shooting in recent U.S. history occurred at the Pulse Nightclub in Orlando, Florida. 49 victims died of their high-velocity gunshot wounds and over 100 were injured. Orlando Regional Medical Center, the regional Level I trauma center, was located only three blocks from the nightclub and received the majority of the victims. During the mass casualty response, 441 units of blood were transfused with the public ultimately donating over 17,000 units of blood in response to the tragedy. Lessons learned from this mass casualty response will be discussed.​
Chief John Mina, Police Cheif, Orlando Police Department
Michael Cheatham, MD, Chief Surgical Quality Officer, Orlando Regional Medical Center  

​9:45 am - 11:15 am            T/S - Serology and Transfusion Reactions

HLA  Antibody Screen - Retrospective Review ,  Lorena Aranda, MSHS, BB, MT, SBB (ASCP)cm
This program will discuss an overview of the HLA system. We will discuss a summary of regulatory requirements from agencies for HLA antibody screen testing of whole blood donors. Audience will be presented retrospective HLA antibody screen data collected tested by QualTex Laboratories.  Intended Audience:  MT, MD; Level:  Basic

TRALI/TACO Similarities and Difference,
Juan Merayo-Rodriquez, MD
Review of TRALI and TACO clinical characteristics, risk factors, impact in blood banking and transfusion medicine. Updated scientific articles and references to help bring awareness to our healthcare community and improve patient outcomes regarding transfusion medicine best practices.  Intended Audience:  Clinical and laboratory staff involved in transfusion medicine; Level:  Intermediate

Mitigation of Daratumumab Interfarence, 
Leslie Vinson, MT(ASCP)SBB
Darzalex (daratumumab) is a promising new monoclonal antibody therapy for patients with refractory multiple myeloma cells. Darzalex administration results in RBC pan-reactivity and potential significant delay in the provision of needed blood products for patients receiving Darzalex and requiring transfusion. This presentation describes the mechanisms at work and presents several strategies that may be used to successfully mitigate serologic mechanisms at work and presents several straties that may be used to successfully mitigate serologic interference and safely transfuse patients receiving Daralex therapy. Our experience developing processes to successfully support these patients at University of Colorado Hospital will be shared.  Intended Audience:  Medical Technologists ; Level:  Intermediate

​2:45 pm - 4:15 pm              T/S - Blood Componants

Refrigerated (4C) Platelets: New Opportunities for Improving the Care of Bleeding Patients​​​​​​​ , Kristin Reddoch, MD  
The use of room temperature (RT) platelets (PLTs) for treatment of trauma, especially under austere environments, is sub-optimal due to a short shelf life, high risk of bacterial contamination, and decline in PLT function over storage. Cold storage (4C) of PLTs has re-emerged as a viable alternative to RT due to slower bacterial growth and better preservation of PLT function but also causes increased PLT activation. In this talk we will show data from our lab¿previously published and recent discoveries¿showcasing the superior hemostatic properties of cold-stored PLTs as well as ways to mitigate cold-stored PLT activation, namely through the use of platelet additive solutions (PASs).
 Intended Audience:  General, Scientific; Level:  Basic

Serological Strategies for Solving the Sickle Cell Transfusion Puzzle, Nancy Benitez, MHS (ASCP)SBB
The majority of patients with Sickle Cell Anemia (SCD) requires transfusion at some point in their life to reduce complications. This session will describe strategies to find suitable donors to prevent alloimmunization of non-alloimmunized SCD patients. It will also outline serological tools to identify antibodies developed by chronically transfused patients. Our goal is to have enough antigen matched units available to provide compatible blood to this special group of patients. Case studies will supplement the review.  
Intended Audience:  Lab Technologists, MD, Supervisors, Manager; Level:  Basic

Emerging Pathogens in Transfusion Medicine, Louis Katz, MD
This presentation will be a survey of the pathogens of greatest current and future interest and approaches to risk mitigation.  
Intended Audience:  Blood Bankers; Level:  Intermediate

​Saturday May 27

​8:15 am - 9:30 am               Oral Abstract Presentations

Effect of 0.2M Dithiothreitol on Red Cell Antigen Integrity on Reagent Red Blood Cells, Heike Carrel, Carter BloodCare:  Sol Haberman Award Winner

Validation of Styrofoam Coolers for use During Massive Transfusion Protocol, Lauren King, MD, University of Oklahoma Medical Center

Maximize Apheresis Plasma, Geri Venable, LifeShare Blood Centers

Inactivation of T Lymphocytes in Platelets and Plasma Components using Amotosale, Adonis Stassinopoulos, Cerus Corporation  Presented by: Marion Lanteri

​9:45 am - 11:15 am            T/S - Patient Blood Management

AABB Platelet Guidelines- what does it mean to my practice?, Richard Gammon, MD
Each year 2.5 million platelet doses are administered with a cost of at least $2.5 billion. This session will cover the origin of platelet transfusion thresholds and current AABB recommendations. There will be a discussion of the causes of platelet refractoriness and approaches to patient treatment. Finally, a number of case presentations will allow the audience to apply what was learned during the session.  Intended Audience:  MT, MD; Level:  Basic

​The “D” Dilemma: How Do We Treat Weak Ds?, Joann Moulds, PhD, MT(ASCP)SBB
This lecture will review the classification and causes for weak D, partial D and Del. The recent AABB guidelines for transfusion of and the use of RhIgG for weak D patients will be presented. Several methods for RH genotyping will be discussed.  Intended Audience:  Physicians, Technologists; Level:  Intermediate

Polar Medical Operations - Utilization of a Walking Blood Bank, Barbara Bryant, MD, MT(ASCP)SBB
How do you provide emergency blood transfusions when you are geographically isolated? This presentation will discuss the development, training, and implementation of a Walking Blood Bank program located literally at the end of the Earth.  Intended Audience:  All; Level:  Basic

​1:30 pm - 3:00 pm            T/S - Case Studies

The Transfusion Reactions You Don’t Want, Richard Gammon, MD
This session will discuss two case studies in which transfusion reactions occurred. Recognition, treatment and prevention will be covered.  
Intended Audience: All; Level: Intermediate

Donor/Therapeutic Apheresis Cases, Tina Ipe, MD
Donor apheresis is used in the collection of blood components. Therapeutic apheresis is used to treat a variety of medical disorders, which can be fatal without medical intervention. This didactic session will use cases to understand about the available apheresis modalities, important physiologic considerations, and adverse consequences of apheresis and interventions to minimize them.  
Intended Audience: Physicians, fellows, residents and laboratory staff that perform donor and therapeutic apheresis ; Level: Basic

Variations on a Theme: Case Study of a Patient with Anti-U Antibody, Stephanie Bates, MD 
A female patient with Sickle Cell Disease presents with multiple antibodies, including an anti-U. She is actually a U antigen variant, and only U variant blood is available. This presentation will discuss her clinical course, complications and the plan for future transfusions and pregnancies.  Intended Audience: Technologists, physicians and students ; Level: Basic

Molecular Case Study, Roser Hoffman, MT(ASCP)SBBCM 
The presentation will describe a case where molecular and serological results are discrepant. The presentation will cover how alternate molecular methods can resolve the discrepancy.  Intended Audience: Blood Bank technologists and supervisors; Level: Intermediate

Sunday May 28

​8:30 am - 12:00 pm            Technical Scientific and Administrative Award Lectures

Administrative Award Lecture:  Doodles, Graphs and Whiteboards: Reflections on Translating and Integrating Learning Experiences , Elizabeth Waltman, MBA
Advancing from a front-line operational role to an executive position can be a wonderful opportunity, especially within an industry universally focused on saving lives. While working hard is essential to accomplishing each ensuing opportunity and promotion, without the help of others, individual or professional progress is impossible. We all help each other directly or indirectly as being good and bad examples of coworkers, supervisors, leaders and visionaries. How we translate these experiences is our opportunity to carry on the great work of others, or become impediments the future. 

Technical Scientific Award Lecture:  Mitigating Iron Deficiency in Blood Donors: Is it time to give iron with the juice and cookies?, 
Barbara Bryant, MD, MT(ASCP)SBB
Maintaining iron balance in blood donors is challenging. The AABB has recently released AB #17-02 updating strategies to limit or prevent iron deficiency in blood donors. This presentation will examine the recommendations, interventions, and strategies including operational feasibility and potential impact to the blood supply.

Karen Williams Memorial Lecture

KWML Award Lecture:  “First, Do No Harm………..”, Joann Moulds, PhD 
Blood safety is often used in the context of infectious disease. But the goal of safe transfusion should apply equally to the red cell which themselves can cause life-threatening problems. This lecture will discuss the questions: Are we really succeeding in mitigating risks associated with red cell transfusion and what more can be done to decrease this risk?

​Closing Plenary

Personal and Professional Excellence, Exploration and Evolution, Story Musgrave, MD
Musgrave will motivate and inspire you how to figure it out and get the job done right the first time and every time. That is, producing and inspiring a talented, proficient team of professionals to bring the total situation and system to some desired and prescribed outcome. That is, being on same playing field: learning the rules of the game, acquiring a plan and acquiring the skillset to execute that plan with ownership and passion to get to the goal. ​​

Register Now!
Click the button below to complete your online exhibit agreement.  You may choose your booth and sponsorship options now or add them later.

Register Now!